BEGIN:VCALENDAR VERSION:2.0 PRODID:PHP BEGIN:VEVENT DTSTART:20210819 SUMMARY:Prostate Cancer Drug Development Summit DESCRIPTION:
Zenith will be presenting at the Prostate Cancer Drug Development Summit on August 19, 2021. More info can be found HERE.
"Advance the Development of an Epigenetic-based Therapy in Castration-Resistant Prostate Cancer (CRPC)"
• Explore the combination of the BET bromodomain inhibitor ZEN-3694
with enzalutamide: updated results from the Phase 2a trial
• Discover mechanisms of resistance to enzalutamide targeted
by ZEN-3694
• Examine translational data informing patient pre-selection strategy